XML 27 R16.htm IDEA: XBRL DOCUMENT v3.20.4
Note 8 - Stockholders' Equity
9 Months Ended
Dec. 31, 2020
Notes to Financial Statements  
Stockholders' Equity Note Disclosure [Text Block]

Note 8. Stockholders' Equity

 

Public Offerings of Common Stock

On June 12, 2020, we completed the sale and issuance of 600,000 shares of our common stock and on June 19, 2020, our underwriters exercised in full their option to purchase an additional 90,000 shares of our common stock. The offering price to the public was $225.00 per share. The total proceeds we received from the offering, net of underwriting discounts and commissions and other offering expenses was $145,935. 

 

Stock-Based Compensation

Amounts recognized related to stock-based compensation are as follows: 

 

  

Three Months Ended December 31,

  

Nine Months Ended December 31,

 
  

2020

  

2019

  

2020

  

2019

 

Stock-based compensation expense

 $3,611  $3,260  $6,887  $5,310 

Amount of income tax expense (benefit) recognized in earnings

  320   (78)  (1,127)  (986)

Stock-based compensation expense, net of tax

 $3,931  $3,182  $5,760  $4,324 

 

Stock-based compensation expense is included in cost of revenues, selling, general and administrative, and research and development expense in the accompanying unaudited Condensed Consolidated Statements of Operations.

 

The following is a summary of stock option award activity for the nine months ended December 31, 2020 (shares in thousands):

 

  

Stock Options

 
  

Shares Subject to Options

  

Weighted- Average Exercise Price per Share

 

Outstanding at March 31, 2020

  286  $107.72 

Awards granted

  36   226.72 

Awards forfeited or expired

  (12)  116.24 

Awards exercised

  (47)  85.64 

Outstanding as of December 31, 2020

  263  $127.63 
 

The stock options granted during the nine months ended December 31, 2020 vest in equal installments on each of the first three anniversaries of the grant date. 

 

The following is a summary of restricted stock unit ("RSU") award activity for the nine months ended December 31, 2020 (shares in thousands): 

 

  

Time-Based Restricted Stock Units

  

Performance-Based Restricted Stock Units

 
  

Number of Shares

  

Weighted- Average Grant Date Fair Value per Share

  

Number of Shares

  

Weighted- Average Grant Date Fair Value per Share

 

Nonvested at March 31, 2020

  28  $180.15   22  $204.68 

Awards granted

  21   230.36   -   - 

Awards forfeited or expired

  (3)  204.40   (1)  199.50 

Awards distributed

  (8)  196.38   -   - 

Nonvested as of December 31, 2020

  38  $203.29   21  $204.80 

 

The majority of the time-based RSUs granted during the nine months ended December 31, 2020 vest and settle in shares of our common stock, on a one-for-one basis, in equal installments on each of the first three anniversaries of the grant date. Time-based RSUs issued to non-employee directors and a portion of the awards granted to executives of the company vest after a one-year period from the grant date. We recognize the expense relating to RSUs, net of estimated forfeitures, on a straight-line basis over the vesting period.

 

Performance-based RSUs vest upon completion of the service period described in the award agreement and based on achievements of the financial targets described in the award agreements. We recognize the expense relating to the performance-based RSUs based on the probable outcome of achievement of the financial targets, on a straight-line basis over the service period.

 

During the three months ended December 31, 2020, we adjusted our estimate of performance share units expected to vest, based on actual results achieved. As a result, we recorded a cumulative effect catch up of $1,629 during the period ($1,209 net of tax as well as $0.25 per basic and diluted share for the nine months ended December 31, 2020, respectively), which is recorded in general and administrative costs on our condensed consolidated statements of operations. During the quarter ending March 31, 2021, we expect non-cash stock based compensation expense will increase approximately $194 compared to the quarters ended June 30, 2020 and September 30, 2020 as a result of our new estimate of performance share units expected to vest.